MXCT vs PRDS
Comparison between MaxCyte Inc (MXCT, Company) and Pardes Biosciences Inc (PRDS, Company).
MXCT vs PRDS - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
MXCT
$130M
PRDS
$129M
Max Drawdown
MXCT
96.07%
Winner
PRDS
95.01%
Sharpe Ratio
MXCT
-0.47
Winner
PRDS
-0.18
5Y Beta
MXCT
1.29
PRDS
N/A
Industry
MXCT
Medical Devices
PRDS
N/A
P/E Ratio
Winner
MXCT
-3.30
PRDS
-3.02
5Y EPS CAGR
MXCT
12.02%
PRDS
N/A
Debt to Equity
MXCT
0.00%
PRDS
0.00%
Free Cash Flow Yield
Winner
MXCT
-22.65%
PRDS
-60.53%
P/S Ratio
MXCT
4.01
PRDS
N/A
P/B Ratio
Winner
MXCT
0.76
PRDS
0.78
MXCT vs PRDS - Historical Returns
Returns include dividend reinvestment.
1M
Winner
MXCT
+13.46%
PRDS
+2.37%
3M
Winner
MXCT
+55.90%
PRDS
+17.39%
6M
MXCT
-27.61%
Winner
PRDS
+75.61%
1Y
MXCT
-45.62%
Winner
PRDS
-29.41%
5Y(CAGR)
MXCT
-27.40%
PRDS
N/A
Max(CAGR)
Winner
MXCT
-4.48%
PRDS
-60.63%
MXCT vs PRDS - Annual Returns (2019 - 2026)
Returns include dividend reinvestment.
| Year | MXCT | PRDS |
|---|---|---|
| 2026 | -23.87% | N/A |
| 2025 | -62.65% | N/A |
| 2024 | -16.80% | N/A |
| 2023 | -8.20% | +19.34% |
| 2022 | -49.63% | -87.99% |
| 2021 | +525.15% | +54.14% |
| 2020 | +0.00% | N/A |
| 2019 | +2.31% | N/A |
MXCT vs PRDS Drawdown Comparison
The maximum drawdown for MXCT was -96.07%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The maximum drawdown for PRDS was -95.01%, occurring on Nov 29, 2022. This drawdown has not yet recovered.
The current MXCT drawdown is -93.14%. The current PRDS drawdown is -87.31%.
| Rank | MXCT | PRDS |
|---|---|---|
| #1 | -96.07% Sep 3, 2021 - Mar 30, 2026 | -95.01% Dec 30, 2021 - Nov 29, 2022 |
| #2 | -37.58% Jan 22, 2021 - Jul 30, 2021 | N/A |
| #3 | -19.65% Jul 30, 2021 - Sep 3, 2021 | N/A |
Correlation
Correlation between MXCT and PRDS is 0.71 which considered as a strong positive correlation - the stocks tend to move together.
0.71
-101
Select Stocks to Compare
Popular: MXCT vs SPYPRDS vs SPY
More Comparisons
Compare with similar stocks